These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27134245)

  • 1. Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients.
    Liozon E; Dalmay F; Lalloue F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
    J Rheumatol; 2016 Jul; 43(7):1393-9. PubMed ID: 27134245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
    Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
    Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular complications of giant cell arteritis].
    Liozon E; Ly KH; Robert PY
    Rev Med Interne; 2013 Jul; 34(7):421-30. PubMed ID: 23523078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.
    Liozon E; Herrmann F; Ly K; Robert PY; Loustaud V; Soria P; Vidal E
    Am J Med; 2001 Aug; 111(3):211-7. PubMed ID: 11530032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.
    Font C; Cid MC; Coll-Vinent B; López-Soto A; Grau JM
    Br J Rheumatol; 1997 Feb; 36(2):251-4. PubMed ID: 9133940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients.
    González-Gay MA; García-Porrúa C; Llorca J; Hajeer AH; Brañas F; Dababneh A; González-Louzao C; Rodriguez-Gil E; Rodríguez-Ledo P; Ollier WE
    Medicine (Baltimore); 2000 Sep; 79(5):283-92. PubMed ID: 11039076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic Manifestations.
    Sun F; Ma S; Zheng W; Tian X; Zeng X
    Medicine (Baltimore); 2016 Mar; 95(13):e3213. PubMed ID: 27043686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
    Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
    Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.
    Muratore F; Boiardi L; Cavazza A; Aldigeri R; Pipitone N; Restuccia G; Bellafiore S; Cimino L; Salvarani C
    J Autoimmun; 2016 May; 69():94-101. PubMed ID: 27009904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss.
    Chatelain D; Duhaut P; Schmidt J; Loire R; Bosshard S; Guernou M; Pellet H; Piette JC; Sevestre H; Ducroix JP;
    Ann Rheum Dis; 2009 Jan; 68(1):84-8. PubMed ID: 18252763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Giant cell arteritis. A study of 191 patients].
    Armona J; Rodríguez-Valverde V; González-Gay MA; Figueroa M; Fernández-Sueiro JL; Blanco R; Martínez-Taboada V
    Med Clin (Barc); 1995 Dec; 105(19):734-7. PubMed ID: 8523954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
    González-Gay MA; Blanco R; Rodríguez-Valverde V; Martínez-Taboada VM; Delgado-Rodriguez M; Figueroa M; Uriarte E
    Arthritis Rheum; 1998 Aug; 41(8):1497-504. PubMed ID: 9704651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
    Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.
    Gonzalez-Gay MA; Piñeiro A; Gomez-Gigirey A; Garcia-Porrua C; Pego-Reigosa R; Dierssen-Sotos T; Llorca J
    Medicine (Baltimore); 2004 Nov; 83(6):342-347. PubMed ID: 15525846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for severe cranial ischaemic complications in giant cell arteritis.
    Hočevar A; Ješe R; Tomšič M; Rotar Ž
    Rheumatology (Oxford); 2020 Oct; 59(10):2953-2959. PubMed ID: 32125431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.
    Chen JJ; Leavitt JA; Fang C; Crowson CS; Matteson EL; Warrington KJ
    Ophthalmology; 2016 Sep; 123(9):1999-2003. PubMed ID: 27297405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.
    Singh AG; Kermani TA; Crowson CS; Weyand CM; Matteson EL; Warrington KJ
    J Rheumatol; 2015 Feb; 42(2):309-15. PubMed ID: 25512481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.